A double-blind, randomized, placebo-controlled video capsule endoscopy trial on the safety and efficacy of Rifaximin-EIR 800 mg BID to prevent intestinal injury caused by a two-weeks-treatment of diclofenac SR 75 mg BID plus omeprazole 20 mg OD in 60 healthy volunteers | Publicación